Nexell Therapeutics Inc.:
The Irvine supplier of therapeutic and diagnostic products posted a first-quarter net loss of $9.3 million, or 13 cents a share, compared with a year-earlier net loss of $7.2 million, or 10 cents a share. Revenue declined 13% to $4.8 million.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
